-
RNAZ Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
TransCode Therapeutics (RNAZ)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.88 mm | 1.88 mm | 1.88 mm | 1.88 mm | 1.88 mm | 1.88 mm |
Cash burn (monthly) | 492.90 k | 464.76 k | 721.80 k | 1.22 mm | 1.30 mm | 1.32 mm |
Cash used (since last report) | 2.51 mm | 2.37 mm | 3.68 mm | 6.23 mm | 6.65 mm | 6.74 mm |
Cash remaining | -638.02 k | -494.50 k | -1.81 mm | -4.36 mm | -4.78 mm | -4.86 mm |
Runway (months of cash) | -1.3 | -1.1 | -2.5 | -3.6 | -3.7 | -3.7 |
13F holders | Current |
---|---|
Total holders | 8 |
Opened positions | 1 |
Closed positions | 12 |
Increased positions | 3 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 177.03 mm |
Total shares | 5.87 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Tiedemann Michael | 2.75 mm | $28.44 mm |
Lind Global Fund II | 2.50 mm | $570.00 k |
Tang Capital Partners | 354.70 k | $0.00 |
Geode Capital Management | 121.77 k | $69.53 mm |
Private Capital Management | 80.68 k | $46.07 mm |
Sheets Smith Wealth Management | 50.14 k | $28.63 mm |
Tower Research Capital | 6.47 k | $3.70 mm |
FMR | 175.00 | $100.00 k |
Proequities | 0.00 | $0.00 |
3i | 0.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Jun 24 | Marquet Magda | Stock Option Common Stock | Grant | Acquire A | No | No | 1.2 | 70,000 | 84.00 k | 70,000 |
14 Jun 24 | Thomas A Fitzgerald | Stock Option Common Stock | Grant | Acquire A | No | No | 1.2 | 650,000 | 780.00 k | 650,000 |
14 Jun 24 | Philippe Calais | Stock Option Common Stock | Grant | Acquire A | No | No | 1.2 | 70,000 | 84.00 k | 70,000 |
14 Jun 24 | Erik Manting | Stock Option Common Stock | Grant | Acquire A | No | No | 1.2 | 70,000 | 84.00 k | 70,000 |
28 Sep 23 | Thomas A Fitzgerald | Common Stock | Buy | Acquire P | No | No | 0.51 | 49,350 | 25.17 k | 56,318 |